Metabolomics analysis underlay mechanisms in the renal impairment of mice caused by combination of aflatoxin M1 and ochratoxin A

文献类型： 外文期刊

第一作者： Wang, Ziwei

作者： Wang, Ziwei;Gao, Yanan;Huang, Xin;Huang, Shengnan;Yang, Xue;Wang, Jiaqi;Zheng, Nan;Wang, Ziwei;Gao, Yanan;Huang, Xin;Huang, Shengnan;Yang, Xue;Wang, Jiaqi;Zheng, Nan;Wang, Ziwei;Gao, Yanan;Huang, Xin;Huang, Shengnan;Yang, Xue;Wang, Jiaqi;Zheng, Nan;Wang, Ziwei;Gao, Yanan;Huang, Xin;Huang, Shengnan;Yang, Xue;Wang, Jiaqi;Zheng, Nan

作者机构：

关键词： aflatoxin M1; ochratoxin A; metabolomics; nephrotoxicity; LysoPCs

期刊名称：TOXICOLOGY （ 影响因子：4.221； 五年影响因子：4.704 ）

ISSN： 0300-483X

年卷期： 2021 年 458 卷

页码：

收录情况： SCI

摘要： Aflatoxin M1 (AFM1) and ochratoxin A (OTA) are pernicious mycotoxins widely co-existing in the environment. However, nephrotoxicity and underlying mechanism induced by AFM1 coupled with OTA still remain to be explored. In this study, CD-1 mice were treated with 3.5 mg/kg b.w. AFM1, OTA, and AFM1 + OTA for 35 days, and UPLC-MS-based metabolomics method was effectuated to investigate metabolomic profiles of mice kidney. Subsequent experiments on human renal proximal tubular (HK-2) cells were performed to dig out the causal connections between distinguished differential metabolites and nephrotoxicity. Compared with DMSO vehicle group, all three toxin treatments (AFM1 and OTA alone, and in combination) significantly reduced final body weight, and remarkably elevated the concentration of serum creatinine (SCr) and caused abnormal histological phenotypes (shown by histopathological slices). OTA, AFM1 + OTA but not AFM1 reduced the relative weight index of kidney. These phenotypic results indicated that AFM1 and OTA were both toxic to the body, and it seemed that OTA exhibited a notable impairment to kidney while AFM1 had similar but limited effect compared with OTA. Further metabolomics analysis showed that when AFM1 and OTA were combined together, OTA exerted dominant effect on the alteration of metabolic processes. There were few differences in the number of changed metabolites between OTA and AFM1 + OTA group. Among the differentially expressed metabolites affected by OTA, and AFM1 + OTA, lysophosphatidylcholines (LysoPCs) were identified as the main type with significant upregulation, in which LysoPC (16:0) accounted for the most prime proportion. Western blotting results of HK-2 cells showed that single OTA and AFM1 + OTA increased the apoptotic protein expressions of Bax, caspase 3 and PARP, and decreased the expression of Bcl-2; while AFM1 only raised the expression of caspase 3. LysoPC (16:0) but not LysoPC (18:1) lifted the protein level of caspase 3 and PARP in HK-2 cells, and reduced the level of Bcl-2. Taken together, this study is the first effort trying to assess nephrotoxicity of AFM1 with OTA, and we guessed that OTA had a more pronounced toxicity to kidney in contrast to AFM1. No obvious synergism between AFM1 and OTA was found to contribute to the occurrence or development of nephropathy. LysoPC (16:0) might be the pivotal metabolite in response to single OTA and combined AFM1 + OTA engendering renal injury.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序